Breaking News Instant updates and real-time market news.

GALT

Galectin Therapeutics

$4.38

0.52 (13.47%)

08:24
01/04/18
01/04
08:24
01/04/18
08:24

Galectin Therapeutics price target raised to $8 from $3 at Roth Capital

Roth Capital analyst Yasmeen Rahimi raised her price target for Galectin Therapeutics to $8 from $3 after the company announced its $10M unsecured line of credit from Richard Uihlein, new director and long-term shareholder, and 1M stock purchase warrants exercisable at $5/share. The analyst believes this was a needed change and the best strategic choice in eliminating financial pressure through 2019, favorably positioning Galectin Therapeutics in potentially securing a lucrative partnership. Rahimi reiterates a Buy rating on the shares.

GALT Galectin Therapeutics
$4.38

0.52 (13.47%)

10/19/17
ROTH
10/19/17
INITIATION
Target $8
ROTH
Buy
Galectin Therapeutics initiated with a Buy at Roth Capital
Roth Capital analyst Yasmeen Rahimi started Galectin Therapeutics with a Buy rating and $8 price target based on her confidence in the clinical success of the company's lead compound for the treatment of liver cirrhosis.
11/28/17
HCWC
11/28/17
NO CHANGE
Target $6
HCWC
Buy
Galectin Therapeutics price target raised to $6 from $3.50 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for Galectin Therapeutics to $6 ahead of the Phase 2b NASH-CX trial readout, which he expects next week. With few therapeutic options in development for the most severely afflicted nonalcoholic steatohepatitis patients, the approvability bar is fairly low, Arce tells investors in a research note. He keeps a Buy rating on Galectin ahead of the NASH-CX readout.
12/07/17
HCWC
12/07/17
NO CHANGE
Target $10
HCWC
Buy
H.C. Wainwright says market wrong, ups Galectin target to $10
H.C. Wainwright analyst Ed Arce raised his price target for Galectin Therapeutics to $10 from $6 saying the market got wrong, "again," the company's Phase 2b NASH-CX trial results, which featured a miss on the overall primary efficacy endpoint. The corresponding stock selloff reflects the "inability of many biotech investors to recognize any value from a trial result that does not myopically present as a 'clean in,'" Arce tells investors in a research note. He believes the study is a "landmark" for the treatment of cirrhosis, "not only because it appears to offer the first ever pharmacological benefit in NASH cirrhosis (across several parameters), but also because it defines a highly clinically significant and easily identifiable patient sub-population for treatment: cirrhotics with mild portal hypertension." The analyst sees multiple paths available to Galectin for a registrational Phase 3 program and he reaffirms his Buy rating on the shares.
12/07/17
ROTH
12/07/17
NO CHANGE
Target $3
ROTH
Buy
Galectin Therapeutics price target lowered to $3 from $10 at Roth Capital
Roth Capital analyst Yasmeen Rahimi lowered her price target for Galectin Therapeutics to $3 from $10 after the company announced that its Phase 2b NASHCX trial in 161 cirrhotic NASH patients missed its primary endpoint. However, the analyst still sees a few positive points such as clean safety, and reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

PETQ

PetIQ

$28.26

1 (3.67%)

, PRSP

Perspecta

$21.64

-0.31 (-1.41%)

19:00
08/14/18
08/14
19:00
08/14/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: PetIQ…

PETQ

PetIQ

$28.26

1 (3.67%)

PRSP

Perspecta

$21.64

-0.31 (-1.41%)

FENG

Phoenix New Media

$4.12

-0.055 (-1.32%)

EGN

Energen

$73.15

1.76 (2.47%)

FANG

Diamondback Energy

$133.75

1.84 (1.39%)

ADNT

Adient

$42.65

0.19 (0.45%)

ERI

Eldorado Resorts

$43.85

0.55 (1.27%)

TEVA

Teva

$22.12

0.17 (0.77%)

CASA

Casa Systems

$15.62

-0.17 (-1.08%)

A

Agilent

$66.72

0.77 (1.17%)

CREE

Cree

$50.17

-0.11 (-0.22%)

VRAY

ViewRay

$9.89

-0.01 (-0.10%)

CRZO

Carrizo Oil & Gas

$24.31

0.62 (2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 19

    Aug

  • 21

    Aug

  • 28

    Aug

  • 04

    Sep

  • 10

    Sep

  • 16

    Sep

  • 15

    Aug

  • 15

    Aug

AAP

Advance Auto Parts

$156.01

11.22 (7.75%)

18:47
08/14/18
08/14
18:47
08/14/18
18:47
Upgrade
Advance Auto Parts rating change  »

Advance Auto Parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

SPHS

Sophiris Bio

$2.74

0.13 (4.98%)

18:37
08/14/18
08/14
18:37
08/14/18
18:37
Recommendations
Sophiris Bio analyst commentary  »

Sophiris Bio topsalycin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$52.87

0.65 (1.24%)

, GOOG

Alphabet

$1,241.95

6.85 (0.55%)

18:30
08/14/18
08/14
18:30
08/14/18
18:30
Hot Stocks
Verizon to partner with YouTube TV for 5G residential broadband package »

Verizon (VZ) announced it…

VZ

Verizon

$52.87

0.65 (1.24%)

GOOG

Alphabet

$1,241.95

6.85 (0.55%)

GOOGL

Alphabet Class A

$1,258.15

9.39 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 22

    Aug

  • 18

    Sep

  • 20

    Sep

  • 28

    Oct

NVDA

Nvidia

$261.47

5.39 (2.10%)

18:27
08/14/18
08/14
18:27
08/14/18
18:27
Upgrade
Nvidia rating change  »

Nvidia double-upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

ORCL

Oracle

$48.23

0.21 (0.44%)

, RMNI

Rimini Street

$6.01

0.11 (1.86%)

18:26
08/14/18
08/14
18:26
08/14/18
18:26
Hot Stocks
Court grants Oracle's motion for permanent injunction against Rimini Street »

For the second time, a…

ORCL

Oracle

$48.23

0.21 (0.44%)

RMNI

Rimini Street

$6.01

0.11 (1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$261.47

5.39 (2.10%)

18:22
08/14/18
08/14
18:22
08/14/18
18:22
Upgrade
Nvidia rating change  »

Nvidia double-upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

CVS

CVS Health

$71.39

1.88 (2.70%)

18:20
08/14/18
08/14
18:20
08/14/18
18:20
Hot Stocks
CVS Health says 'actively working' with Ohio Managed Medicaid clients »

"CVS Health is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

VRAY

ViewRay

$9.89

-0.01 (-0.10%)

18:18
08/14/18
08/14
18:18
08/14/18
18:18
Syndicate
ViewRay $125M Spot Secondary; price range $9.25-$9.50 »

Morgan Stanley, Jefferies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 04

    Sep

CRZO

Carrizo Oil & Gas

$24.31

0.62 (2.62%)

18:16
08/14/18
08/14
18:16
08/14/18
18:16
Syndicate
Carrizo Oil & Gas 9.5M share Spot Secondary; price range $22.90-$23.50 »

Citi and Goldman Sachs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 15

    Aug

WTW

Weight Watchers

$77.39

1.8 (2.38%)

18:12
08/14/18
08/14
18:12
08/14/18
18:12
Syndicate
Weight Watchers 6M share Block Trade; price range $76.00-$77.00 »

Morgan Stanley is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERI

Eldorado Resorts

$43.85

0.55 (1.27%)

, PAY

Verifone

$23.00

-0.02 (-0.09%)

18:05
08/14/18
08/14
18:05
08/14/18
18:05
Hot Stocks
S&P announces changes to S&P MidCap 400 index »

S&P Dow Jones Indices…

ERI

Eldorado Resorts

$43.85

0.55 (1.27%)

PAY

Verifone

$23.00

-0.02 (-0.09%)

ADNT

Adient

$42.65

0.19 (0.45%)

DCT

DCT Industrial

$65.28

-0.34 (-0.52%)

PLD

Prologis

$64.05

-0.38 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$116.73

0.7 (0.60%)

18:00
08/14/18
08/14
18:00
08/14/18
18:00
Hot Stocks
Celanese to increase price of acetate flake by 50c/kg »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

GDDY

GoDaddy

$75.81

0.52 (0.69%)

17:43
08/14/18
08/14
17:43
08/14/18
17:43
Syndicate
GoDaddy files to sell 10,398,942 shares of Class A common stock »

Selling stockholders are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAG

MAG Silver

$8.64

0.07 (0.82%)

17:41
08/14/18
08/14
17:41
08/14/18
17:41
Earnings
MAG Silver reports Q2 EPS (3c), consensus (2c) »

Reports cash and cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$113.07

0.09 (0.08%)

17:39
08/14/18
08/14
17:39
08/14/18
17:39
Hot Stocks
SPDR Gold Trust holdings fall to 776.65MT from 784.60MT »

This is the 2nd…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNES

SenesTech

$0.95

-0.0779 (-7.60%)

17:36
08/14/18
08/14
17:36
08/14/18
17:36
Syndicate
Breaking Syndicate news story on SenesTech »

SenesTech files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXWL

Maxwell

$3.98

0.59 (17.40%)

17:36
08/14/18
08/14
17:36
08/14/18
17:36
Hot Stocks
Breaking Hot Stocks news story on Maxwell »

VIEX Capital Advisors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$21.44

0.26 (1.23%)

, SYMC

Symantec

$18.66

-0.15 (-0.80%)

17:35
08/14/18
08/14
17:35
08/14/18
17:35
Hot Stocks
Appaloosa adds KeyCorp, exits NVIDIA »

David Tepper's…

KEY

KeyCorp

$21.44

0.26 (1.23%)

SYMC

Symantec

$18.66

-0.15 (-0.80%)

CFG

Citizens Financial

$40.39

0.54 (1.36%)

VST

Vistra Energy

$22.41

0.31 (1.40%)

EDU

New Oriental Education

$85.07

-0.08 (-0.09%)

QQQ

Invesco QQQ Trust

$181.44

1.1 (0.61%)

AMAT

Applied Materials

$48.38

0.12 (0.25%)

SMH

Market Vectors Semiconductor

$105.49

-0.25 (-0.24%)

ALL

Allstate

$98.35

0.2 (0.20%)

NVDA

Nvidia

$261.47

5.39 (2.10%)

MU

Micron

$50.62

-0.73 (-1.42%)

WDC

Western Digital

$64.98

0.75 (1.17%)

LNG

Cheniere Energy

$63.48

-0.13 (-0.20%)

WFC

Wells Fargo

$58.07

0.43 (0.75%)

PAH

Platform Specialty Products

$12.26

0.08 (0.66%)

BABA

Alibaba

$172.53

-5.12 (-2.88%)

NRG

NRG Energy

$32.83

0.33 (1.02%)

BAC

Bank of America

$30.80

0.33 (1.08%)

MGM

MGM Resorts

$28.99

-0.04 (-0.14%)

ALY

Allis-Chalmers

$0.00

(0.00%)

FB

Facebook

$181.11

1.03 (0.57%)

AGN

Allergan

$184.44

0.18 (0.10%)

GOOG

Alphabet

$1,241.95

6.85 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 16

    Aug

  • 16

    Aug

  • 22

    Aug

  • 23

    Aug

  • 05

    Sep

  • 10

    Sep

  • 11

    Sep

  • 12

    Sep

  • 18

    Sep

  • 20

    Sep

  • 27

    Sep

  • 01

    Oct

  • 18

    Oct

  • 19

    Oct

  • 28

    Oct

  • 30

    Oct

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

PETQ

PetIQ

$28.26

1 (3.67%)

17:33
08/14/18
08/14
17:33
08/14/18
17:33
Earnings
PetIQ reports Q2 adjusted EBITDA of $15.8M versus $7.6M in Q2 last year »

The company reported Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

TTNP

Titan Pharmaceuticals

$0.90

0.01 (1.12%)

17:33
08/14/18
08/14
17:33
08/14/18
17:33
Syndicate
Breaking Syndicate news story on Titan Pharmaceuticals »

Titan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHO

M/I Homes

$25.20

0.4 (1.61%)

17:32
08/14/18
08/14
17:32
08/14/18
17:32
Hot Stocks
M/I Homes approves $50M share repurchase program »

M/I Homes announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENPH

Enphase Energy

$5.05

-0.315 (-5.87%)

17:31
08/14/18
08/14
17:31
08/14/18
17:31
Syndicate
Breaking Syndicate news story on Enphase Energy »

Enphase Energy files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWGH

GWG Holdings

$7.55

-0.34 (-4.31%)

17:30
08/14/18
08/14
17:30
08/14/18
17:30
Hot Stocks
Breaking Hot Stocks news story on GWG Holdings »

GWG Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

GD

General Dynamics

$193.62

1.82 (0.95%)

17:29
08/14/18
08/14
17:29
08/14/18
17:29
Hot Stocks
General Dynamics awarded $147.7M U.S. Navy contract »

General Dynamics National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.